Navigation Links
Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
Date:3/2/2010

t be regarded as a representation by Amicus that any of its plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Amicus might make or by known or unknown risks and uncertainties including the risk that adverse events could cause the cessation or delay of the closing of the proposed offering. In addition, all forward looking statements are subject to other risks and uncertainties detailed in our Annual Report on Form 10-K for the year ended December 31, 2008, as supplemented by our subsequent public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Amicus undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

SOURCE Amicus Therapeutics

Back to top

RELATED LINKS
http://www.amicustherapeutics.com/

'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  4WEB Medical announces the ... foot and ankle osteotomy implants on the market ... Society annual meeting in Chicago . ... of a surgeon,s osteotomy needs with 74 size options included ... had smaller offerings of only 15 to 18 implant sizes, ...
(Date:9/19/2014)... NORWALK, Conn. , Sept. 19, 2014 ... , a leading online community to help oncologists ... newest information available regarding the use of targeted therapies ... blood cancer research and treatment.  Every ... as a way to raise awareness about blood cancers—helping ...
(Date:9/19/2014)... 19, 2014  Pressure BioSciences, Inc. (OTCQB: PBIO) ... received and approved all parts required to build ... begun to manufacture the new PCT-based instrument system.  ... ready for shipment by mid-October and that additional ... a rate of about one per week thereafter.  ...
Breaking Medicine Technology:4WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3
(Date:9/19/2014)... More states are passing legislation permitting or requiring schools ... child having a severe allergic reaction. Epinephrine auto-injectors ... that can lead to throat swelling, breathing difficulties, a ... In people with severe allergies to certain foods, ... certain drugs, anaphylaxis can occur within moments of exposure ...
(Date:9/19/2014)... Medical College of Wisconsin (MCW) scientists has identified a new ... mice and in humans. The findings are published in the ... Leah Solberg Woods, Ph.D., associate professor of pediatrics at MCW ... Institute, led the study and is the corresponding author of ... gene called Tpcn2 in which a variant was associated with ...
(Date:9/19/2014)... Wellesley, MA (PRWEB) September 19, 2014 ... ANTIFUNGAL DRUGS: TECHNOLOGIES AND GLOBAL MARKETS , the global ... to nearly $13.9 billion by 2018, with a five-year ... over-the-counter (OTC) segment is growing at a steady 3.8% ... is often presenting lower sales, coupled with the incidence ...
(Date:9/19/2014)... York, NY (PRWEB) September 19, 2014 ... presale tickets for her 2015 “Honeymoon” Tour. ... code ARIANA-2015 for additional savings at the checkout. , Ariana ... City, MO (Independence Event Center) , Feb. 28, 2015: Milwaukee, ... Paul, MN (Xcel Energy Center) , March 03, 2015: Chicago, ...
(Date:9/19/2014)... material graphene has been used to detect molecules that ... The biosensor has been shown to be more than ... use, and was able to provide results in a ... rapid, point-of-care diagnostic tool for patients. , The biosensor ... journal 2D Materials . , To develop a ...
Breaking Medicine News(10 mins):Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 2Health News:More Schools Stocking Shots That Counter Serious Allergic Reactions 3Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 2Health News:Global Market for Human Antifungal Therapeutics to Reach Nearly $13.9 Billion in 2018; Over-The-Counter (OTC) Segment Growing At 3.8% CAGR 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4Health News:Graphene sensor tracks down cancer biomarkers 2
... Mich. Doctors are increasingly using a convenient blood glucose ... the University of Michigan,s C.S. Mott Children,s Hospital shows it,s ... The hemoglobin A1c test has become the preferred way ... diabetes but show no symptoms. The simple test measures longer-term ...
... for seniors to remain living in their homes. The ... that more than one-third of caregivers had difficulty reading ... errors when sorting medications into pillboxes. The study ... Internal Medicine . It has been published online. ...
... A U.S. law protects drug makers from lawsuits filed for ... ruled Tuesday. The court, in a six-to-two vote, decided ... problems were caused by a diphtheria, tetanus and pertussis vaccine ... sued the vaccine maker, Wyeth, which was acquired by Pfizer ...
... Three American College of Radiology commission and committee chairs ... Chancellors will outline strategies for transforming computed tomography (CT) ... at a Feb. 24, 25 event sponsored by the ... on Management of Radiation Dose in Computerized Tomography ...
... (HealthDay News) -- Concentrations of bisphenol A -- a chemical ... Canadians than Americans, a new study has found. Bisphenol ... products, from food packaging to electronic equipment and cars. Studies ... animals and this has raised concerns that it may have ...
... Feb. 22 (HealthDay News) -- Despite suggestions that hard ... known as atopic eczema, a new British study has ... sufferers. "Although the outcome is disappointing in terms ... outcome of the trial is very clear," the study,s ...
Cached Medicine News:Health News:Convenient blood test not as effective for diagnosing diabetes in children 2Health News:Struggling to follow doctor's orders 2Health News:Supreme Court Rejects Vaccine-Safety Lawsuit 2Health News:ACR commission and committee chairs and former board chair to present at NIH Radiation Dose Summit 2Health News:Plastics Chemical Affects U.S. More Than Canada: Study 2Health News:Softening Water Does Not Seem to Ease Eczema 2
... ORTHOSET Radiopaque Bone Cement ... system: a sterile,ampule containing bone ... pack, and a sterile polyethylene ... a peelable pouch. The interiors ...
Antibiotics (Gentamicin) loaded, high viscosity bone cement for digital use with an average setting time of approx. 6-8 Min., 41.6g of powder and 14.4g of liquid....
... new thinking to address common problems associated ... mm diameter outer arthroscope sheath, the shorter, ... Videoscope has superior access and mobility in ... and especially in the elbow and ankle. ...
... The OMEGA 180 features a wide ... One-Step Small and Variable Pupil Control (U.S. ... pupil sizes down to 1.2mm. Heine's unique ... illumination, making learning BIO easier, and simplifying ...
Medicine Products: